Add BrightSurf on Google Email

UCLA researchers discover new approach for treating autism and conditions caused by a single faulty gene copy

Researchers at UCLA Health have shown that boosting the activity of a healthy gene copy can offset the effects of a mutation linked to autism. The approach, using a modified form of CRISPR, targets enhancers to control gene expression, offering a new direction for treating autism and related neurodevelopmental conditions.

Could overlooked unstable Repeat DNA explain the missing heritability of schizophrenia and bipolar disorder? A revised hypothesis points to glutamine

Researchers propose that unstable repeat DNA may contribute to the missing heritability of schizophrenia and bipolar disorder, suggesting a link to glutamine variation. The proposed mechanism involves glutamine dysregulation in astrocytes, which can lead to psychosis.

SourceGenomic Press·JournalGenomic Psychiatry·TypeLiterature review·DateNov 10, 2026

New gene-editing technology brings genetic diseases closer to treatment

Researchers at Aarhus University have demonstrated a new form of gene therapy that can correct genetic defects in patients' own stem cells. The technique, called prime editing, builds on CRISPR technology but works in a different way, inserting a small piece of correct DNA at the precise location of the defect. This method has signific...

SourceAarhus University·JournalScience Translational Medicine·TypeExperimental study·DateOct 13, 2026

Rosalind Franklin deliberately created ‘Photo 51’ after using an earlier image to uncover features of DNA’s helical structure

Rosalind Franklin created 'Photo 51' after using an earlier image, 'Photo 49', to calculate key features of DNA's helical structure. The new research reveals that Franklin carefully planned and produced the high-quality repeat of the earlier image, challenging the long-held belief that she did not recognize its significance.

SourceKing's College London·JournalJournal of the History of Biology·DateOct 9, 2026

Novo Nordisk Foundation renews commitment to investigate genomic mechanisms of disease at Broad Institute in collaboration with Danish scientists

The Novo Nordisk Foundation has renewed its $53 million commitment to the Broad Institute's Center for Genomic Mechanisms of Disease. This funding will accelerate research into the genetic and biological mechanisms underlying type 2 diabetes and obesity, with the goal of identifying new therapeutic targets. The center will expand on it...

Stowers Institute partners with Google DeepMind and leading research institutions to help reveal the regulatory language of the human genome

Researchers have developed the AlphaGenome Atlas, a comprehensive map of more than 9 billion possible single-letter DNA changes. The one-petabyte dataset provides artificial intelligence-generated predictions for the molecular effects of these changes, accelerating understanding of the human genome.

SourceStowers Institute for Medical Research·TypeComputational simulation/modeling·DateSep 8, 2026

How old are you really? Study explains what makes ‘epigenetic clocks’ tick, debuts new prediction tools

Researchers from USC-led study found that different epigenetic clocks capture distinct aspects of cellular aging, while introducing new gene-expression based clocks with stronger predictive power. These tools can better predict age-related disease and mortality by examining DNA methylation patterns and gene expression.

SourceUniversity of Southern California·Journalnpj Aging·TypeData/statistical analysis·DateAug 13, 2026

Chinese Medical Journal review highlights new directions in pulmonary arterial hypertension

A new review highlights how molecular biology advances are reframing PAH as a complex vascular remodeling disease driven by endothelial dysfunction, chronic inflammation, metabolic dysregulation, and genetic susceptibility. Emerging therapies target the BMP/TGF-β pathway, growth factor signaling, and inflammatory pathways.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 11, 2026

New approach opens rare immune cells to genetic risk research

Researchers developed a new method to study long-distance DNA regulation in rare immune cells, uncovering previously hidden connections relevant to autoimmune diseases. The approach prioritized over 100 candidate genes linked to Crohn's disease risk, including CLN3, which was not typically associated with the condition.

SourceCincinnati Children's Hospital Medical Center·JournalNature Genetics·TypeData/statistical analysis·DateAug 4, 2026

Newly discovered mitochondrial microprotein linked to Type 2 diabetes — and shows early promise as a precision treatment

A study at USC discovers a common genetic variant in Indigenous American populations that silences the microprotein MENTSH, restoring it improves insulin signaling and blocks diet-induced weight gain. MENTSH-based therapies could offer a precision-medicine approach to Type 2 diabetes.

SourceUniversity of Southern California·JournalTheranostics·TypeObservational study·DateJul 30, 2026

Single-cell atlases of the human body may not fairly represent global populations, Mount Sinai study finds

A Mount Sinai study found that single-cell atlases, used for mapping the human body and training AI models, may not accurately represent global populations. The analysis of over 13,500 samples revealed an overrepresentation of European ancestry and underrepresentation of Asian and Latino individuals, highlighting the need for diverse a...

New atlas maps potential of genes to predict adverse drug reactions

A new atlas has been developed to map the potential of genes in predicting adverse drug reactions, utilizing a comprehensive analysis of genetic data from the Million Veteran Program. This genomic-led strategy aims to anticipate drug safety effects by identifying key genetic variants associated with adverse reactions.

SourcePLOS·JournalPLOS Genetics·DateJul 16, 2026

Kidney cancer gene reveals an unexpected weakness and a new path for treatment

Researchers discover that kidney cancer cells lacking the tumor suppressor gene SETD2 become highly dependent on protein BCL-xL for survival. By targeting this dependency, they can selectively eliminate SETD2-deficient cancer cells, offering a potential new therapeutic strategy for patients with aggressive subset of kidney cancers.

SourceMedical University of South Carolina·JournalCancer Research·TypeExperimental study·DateJun 29, 2026

University of Bath appoints Yale academic Laura Huckins

The University of Bath has recruited leading psychiatric geneticist Professor Laura Huckins to lead mental health research, focusing on eating disorders and PTSD. She aims to provide answers and treatments for vulnerable populations, combining genetic data and human brain studies to predict individual responses to their environment.

Human traits beyond inherited genes

Researchers at ISTA and Norwegian Institute of Public Health found that environmental factors influenced by parents' genes can significantly impact children's traits like height, body weight, and school performance. The study used genetic and phenotypic data from over 30,000 families to separate direct and indirect genetic effects.

SourceInstitute of Science and Technology Austria·JournalCell Genomics·TypeData/statistical analysis·DateJun 9, 2026

International research team develops AI tool to simplify and scale complete genome assembly, supporting advances in diagnostics and precision medicine

A new AI tool, HERRO, corrects errors in nanopore sequencing reads to produce high-quality complete genome assemblies. This innovation enables researchers to build more accurate and complete genome maps with a simpler workflow, unlocking potential for precision medicine advancements.

Genetic testing allows fast diagnosis of rare pancreatic condition in 98 per cent of babies

A new study from the University of Exeter found that genetic testing can identify the cause of pancreatic agenesis in 98 per cent of cases. This diagnosis allows healthcare professionals to provide families with a better understanding of the condition's impacts, risks, and help them find support.

SourceUniversity of Exeter·JournalThe Lancet Diabetes & Endocrinology·TypeCommentary/editorial·DateJun 1, 2026

Mount Sinai researchers uncover a substantial genetic component to postpartum psychosis, advancing understanding of severe maternal mental illness

Mount Sinai researchers have uncovered a substantial genetic component to postpartum psychosis, a rare psychiatric illness that occurs after childbirth. The study found rare damaging mutations in the HMGCR gene and significant genetic overlap with bipolar disorder, schizophrenia, and autoimmune diseases.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalMolecular Psychiatry·TypeObservational study·DateJun 1, 2026

Researchers map genetics of blood lipids with unprecedented precision

A study published in Nature Communications identified over 50 previously unknown genes that affect lipid composition in the human body. These findings may provide a better understanding of aging processes and pathological conditions such as Alzheimer's disease, diabetes, and cardiovascular dysfunctions.

SourceDZNE - German Center for Neurodegenerative Diseases·JournalNature Communications·TypeObservational study·DateMay 19, 2026

New models enable better therapies against primary sclerosing cholangitis

Recent advancements in animal models, organoid models, and bioengineered organoids have provided new tools for studying primary sclerosing cholangitis. These models replicate the effects of bile retention and inflammation, enabling studies of disease mechanisms, drug screening, and preclinical evaluation.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalPortal Hypertension & Cirrhosis·TypeLiterature review·DateMay 19, 2026

UMass Chan scientists develop gene editing technology capable of rewriting entire chapters of the genome

Researchers have developed a new gene editing technology called 'prime assembly' that allows efficient insertion of large DNA segments into the human genome. This innovation enables treatment of genetic diseases by replacing entire genes, promising substantial progress in treating conditions with multiple mutations.

SourceUMass Chan Medical School·JournalNature·TypeExperimental study·DateMay 13, 2026

Chinese Neurosurgical Journal reports KRAS gene as key driver for brain arteriovenous malformation

A study published in Chinese Neurosurgical Journal reports KRAS gene overexpression associated with brain arteriovenous malformation (bAVM) pathogenesis. The research found altered gene expression profiles linked to cell adhesion, signaling, and mitochondrial function, suggesting KRAS-driven molecular alterations play a role in bAVM de...

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeExperimental study·DateMay 13, 2026

Longevity-linked APOE2 gene variant helps neurons repair DNA and resist aging

The APOE2 gene variant is associated with exceptional longevity and reduced Alzheimer's risk. Research reveals that APOE2 helps human neurons maintain genomic integrity and resist cellular senescence, driving neurodegeneration. This study offers a mechanistic answer to the protective mechanism behind APOE2's role in aging.

SourceBuck Institute for Research on Aging·JournalAging Cell·TypeExperimental study·DateMay 13, 2026

New AI tool developed by Stowers Institute and Helmholtz Munich scientists predicts how cells choose their future — helping uncover hidden drivers of development

Researchers developed RegVelo, an AI framework that models cellular dynamics and gene regulation to predict cellular fate decisions. The model traces developmental trajectories and simulates regulatory interactions, providing insights into hidden drivers of development and potential therapeutic targets.